XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

Results of a prospective, randomized, controlled trial indicate that allopurinol lowers serum uric acid levels and reduces the rate of renal degeneration in patients with mild to moderate chronic ...

although the regulator has required a black box warning highlighting risk of kidney failure. A once-daily drug, Duzallo combines the standard of care treatment, allopurinol, with Ironwood’s ...